SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales figure stood at Rs. 1733.53 millions for the December 2021 quarter. The mentioned figure indicates a growth of about 49.43% as compared to Rs. 1160.08 millions during the year-ago period.The Total revenue for the quarter ended December 2021 of  Rs. 247.37  millions  grew by 250.98% from Rs. 70.48 millions.Operating profit for the quarter ended December 2021 rose to 448.23 millions as compared to 188.57 millions of corresponding quarter ended December 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 1733.53 1160.08 49.43 4045.84 3829.51 5.65 5548.72 5222.21 6.25
Other Income 19.60 32.72 -40.10 36.63 61.21 -40.16 76.71 119.32 -35.71
PBIDT 448.23 188.57 137.70 922.84 794.40 16.17 1191.77 971.37 22.69
Interest 25.64 10.65 140.75 57.61 37.41 54.00 47.90 126.39 -62.10
PBDT 422.59 177.92 137.52 865.23 756.99 14.30 1143.87 844.98 35.37
Depreciation 90.72 65.38 38.76 237.61 191.74 23.92 257.15 232.24 10.73
PBT 331.87 112.54 194.89 627.62 565.25 11.03 886.72 612.74 44.71
TAX 84.50 42.06 100.90 159.88 157.73 1.36 239.79 138.02 73.74
Deferred Tax 4.69 3.73 25.74 9.21 2.77 232.49 -6.12 -30.55 -79.97
PAT 247.37 70.48 250.98 467.74 407.52 14.78 646.93 474.72 36.28
Equity 195.91 195.78 0.07 195.91 195.78 0.07 195.88 195.68 0.10
PBIDTM(%) 25.86 16.25 59.07 22.81 20.74 9.96 21.48 18.60 15.47

Astec Lifesciences Share Price

726.50 -22.90 (-3.06%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
UPL 665.00
PI Industries 3144.45
Bayer CropScience 4900.45
Sharda Cropchem 1109.70
Sumitomo Chemical 441.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×